Modified chitosan as well as preparation method and application thereof

Modified chitosan sponges with succinic acid treatment and blood-stopping polysaccharides address the poor antibacterial performance of chitosan sponges, achieving higher inhibition rates and simplified production.

CN119080964AInactive Publication Date: 2024-12-06WEST ANHUI UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411220813.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-02
Publication Date
2024-12-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Chitosan hemostatic sponges exhibit poor antibacterial effects and low inhibition rates against Staphylococcus aureus and Escherichia coli, with inhibition rates of only 15% and 20% respectively, and have cumbersome production processes.

Method used

Modified chitosan is prepared by reacting chitosan with succinic acid to introduce carboxyl groups, enhancing solubility and antibacterial properties, and combined with blood-stopping polysaccharides to form wound protection sponges through a freeze-drying process.

Benefits of technology

The modified chitosan sponges demonstrate improved antibacterial rates of 25% against Staphylococcus aureus and 35% against Escherichia coli, with simplified production by omitting acid addition steps and enhanced hemostatic properties.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119080964A_ABST
    Figure CN119080964A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of chitosan modification, and discloses modified chitosan as well as a preparation method and application thereof. The preparation method specifically comprises the following steps: preparing gel: preparing the gel from chitosan, water and succinic acid; wherein the ratio of the chitosan to the water to the succinic acid is 3g: 50mL: (6-15g); and preparing the modified chitosan: reacting the gel for 8-24 hours at the temperature of 30 DEG C below zero to 0 DEG C, so as to obtain the modified chitosan. The modified chitosan is used for preparing the wound protection sponge; # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of chitosan modification, and in particular relates to modified chitosan and a preparation method and application thereof. Background Art

[0002] In people's daily work and sports, bleeding may occasionally occur due to abrasions or tissue damage. Severe bleeding may even lead to death. Bleeding wounds are prone to breed bacteria, which increases the difficulty of wound recovery. Therefore, the use of hemostatic materials with antibacterial effects is of great significance in the process of on-site treatment. The hemostatic materials used clinically are mainly divided into absorbable hemostatic materials and non-absorbable hemostatic materials. Non-absorbable materials are placed in the body for a long time, and the body will produce a stress response to foreign objects, and they need to be removed after the hemostasis is completed. Absorbable materials include various animal and plant polysaccharides and biological derivatives, such as collagen, cellulose, gelatin, thrombin, fibrin, fibrinogen, chitosan, starch and alginate. Collagen is a foreign body that can cause allergic reactions in the body. Side effects such as skin allergies increase the chance of wound infection. The oxidation process of oxidized cellulose is relatively complicated, which will produce a high acidic environment, causing inflammatory reactions in tissues, prolonging the time of wound healing, and damaging peripheral nerves, causing neurofibrosis. Gelatin products are not suitable for patients with coagulation disorders. During the hemostasis process, their volume will expand rapidly and compress the tissues and nerves on the wound surface, causing damage. Thrombin has insufficient adhesion to bleeding wounds and is easily washed away in the process of dealing with arterial bleeding or bleeding on large wounds, which limits the use of thrombin.

[0003] Chitosan is a natural animal polysaccharide that can be obtained in large quantities through the deacetylation of chitin. Chitosan itself is non-toxic and has excellent properties of good biocompatibility, non-immunogenicity, and degradability. By acting on red blood cells, it can cause them to aggregate and cause blood coagulation. Therefore, chitosan is also widely used in hemostatic sponges; but chitosan has poor water solubility and the production process of related materials is relatively cumbersome. Chitosan is not easily soluble in water, and the process of preparing neutral hemostatic sponges is relatively difficult. In addition, the mechanical strength of chitosan sponges is insufficient, and the hemostatic rate is too slow. Therefore, in the process of preparing chitosan hemostatic sponges, cross-linking agents are often added to enhance their mechanical strength, and their solubility is increased by modification, or organic and inorganic materials are added to improve the hemostatic effect of hemostatic sponges. The existing chitosan hemostatic sponge has the defect of poor antibacterial effect. The prior art discloses a hemostatic sponge, refer to Xiaohui Wei, Sheng Ding, Polysaccharides-modified chitosanas improved and rapid hemostasis foam sponges [J] Carbohydrate Polymers 2021 (264) 118028. The paper uses the Schiff method to prepare a hemostatic sponge composed of polysaccharide-modified chitosan sponge and oxidized cellulose. However, the antibacterial effect of the chitosan hemostatic sponge prepared by it is too poor, and the inhibition rate of Staphylococcus aureus and Escherichia coli is too low, the inhibition rate is only 15%, and the inhibition rate of Escherichia coli is only 20%. Summary of the invention

[0004] The invention discloses a modified chitosan and a preparation method and application thereof, which solve the problems that the chitosan hemostatic sponge prepared by the prior art has poor antibacterial effect and too low inhibition rate on Staphylococcus aureus and Escherichia coli, the inhibition rate of Staphylococcus aureus is only 15%, and the inhibition rate of Escherichia coli is only 20%.

[0005] A modified chitosan, the structural formula of which is as follows:

[0006]

[0007] The second object of the present invention is to protect the preparation method of the modified chitosan, which specifically comprises the following steps:

[0008] Preparation of gel: chitosan, water and succinic acid are prepared into gel; wherein the chitosan, water and succinic acid are in a ratio of 3g:50mL:6g-15g;

[0009] Preparation of modified chitosan: reacting the gel at -30°C to 0°C for 8h to 24h to obtain the modified chitosan.

[0010] Chitosan is modified with succinic acid, which increases the solubility of chitosan and the reaction rate. The modified chitosan has carboxyl groups, and the weakly acidic environment can inhibit bacterial growth.

[0011] Preferably, the gel is reacted at -10°C for 16 hours to obtain the modified chitosan.

[0012] Preferably, the preparation method of the gel is: after mixing chitosan with water, adding succinic acid and mixing evenly to form the gel.

[0013] The third object of the present invention is to protect the application of the modified chitosan in the preparation of wound protection sponge.

[0014] Preferably, the preparation method of the wound protection sponge is:

[0015] The pH value of the gel is first adjusted to 6.5-7.5, then frozen at -30°C-0°C for 8h-24h, and then freeze-dried at -20°C-0°C for 8h-24h to obtain the wound protection sponge.

[0016] Freeze drying at -20℃ to 0℃ is to further reduce moisture and form pores.

[0017] Preferably, the wound protection sponge also includes blood flow interrupting polysaccharide.

[0018] Preferably, the preparation method of the wound protection sponge is: first adjust the pH value of the gel to 6.5-7.5, add blood flow stopping polysaccharide, mix well and freeze at -30℃ to 0℃ for 8h to 24h, then freeze-dry for 8h to 24h to obtain the wound protection sponge.

[0019] Preferably, the chitosan, water, succinic acid and blood-stopping polysaccharide are in a ratio of 3g:50mL:6g-15g:6g-15g.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] 1. The present invention uses succinic acid to modify chitosan to improve the antibacterial ability of chitosan. The antibacterial rate of the prepared wound sponge against Staphylococcus aureus reaches 25%, and the antibacterial rate against Escherichia coli reaches 35%; while the antibacterial rate of ordinary wound sponges against Staphylococcus aureus is only 15%, and the antibacterial rate against Escherichia coli is only 20%.

[0022] 2. In the prior art, 1% acetic acid is generally added when preparing modified chitosan to increase the solubility of chitosan. The preparation method of modified chitosan provided by the present invention can avoid the acid addition step in the preparation process. Although acid addition has no negative impact on the antibacterial effect, omitting the acid addition step can simplify the operation, save operation time and cost.

[0023] 3. The present invention adds blood-stopping polysaccharide to the wound sponge to enhance the blood coagulation effect, so that the wound sponge has the effect of antibacterial hemostasis. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 This is an infrared characterization image of succinic acid-modified chitosan prepared in Example 4 of the present invention;

[0025] Figure 2 This is a schematic diagram of a wound protection sponge prepared in Example 4 of the present invention;

[0026] Figure 3 This is a SEM image of the wound protection sponge prepared in Example 4 of the present invention;

[0027] Figure 4 This is a schematic diagram of a wound protection sponge prepared in Example 5 of the present invention;

[0028] Figure 5 This is a SEM image of the wound protection sponge prepared in Example 5 of the present invention. DETAILED DESCRIPTION

[0029] The following will be combined with the specific implementation of the present invention to clearly and completely describe the technical solutions in the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0030] The methods described in the embodiments of the present invention are conventional methods unless otherwise specified. The materials, reagents, etc. used can be obtained from commercial sources unless otherwise specified.

[0031] Example 1

[0032] A modified chitosan, the structural formula of which is as follows:

[0033]

[0034] A method for preparing modified chitosan specifically comprises the following steps:

[0035] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 6 g of succinic acid was added and mixed to prepare a gel.

[0036] Preparation of modified chitosan: freezing the gel at -30°C for 8 hours to obtain the modified chitosan.

[0037] A method for preparing a wound protection sponge specifically comprises the following steps:

[0038] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 6 g of succinic acid was added and mixed to prepare a gel.

[0039] Preparation of wound protection sponge: first adjusting the pH value of the gel to 6.5, then freezing at -30°C for 8 hours, and then freeze-drying for 8 hours to obtain the wound protection sponge.

[0040] Example 2

[0041] A modified chitosan, the structural formula of which is as follows:

[0042]

[0043] A method for preparing modified chitosan specifically comprises the following steps:

[0044] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 9 g of succinic acid was added and mixed to prepare a gel.

[0045] Preparation of modified chitosan: freezing the gel at -15°C for 14 hours to obtain the modified chitosan.

[0046] A method for preparing a wound protection sponge specifically comprises the following steps:

[0047] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 9 g of succinic acid was added and mixed to prepare a gel.

[0048] Preparation of wound protection sponge: first adjusting the pH value of the gel to 6.5, then freezing at -15°C for 14 hours, and then freeze-drying for 14 hours to obtain the wound protection sponge.

[0049] Example 3

[0050] A modified chitosan, the structural formula of which is as follows:

[0051]

[0052] A method for preparing modified chitosan specifically comprises the following steps:

[0053] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 12 g of succinic acid was added and mixed to prepare a gel.

[0054] Preparation of modified chitosan: freezing the gel at -10°C for 20 hours to obtain the modified chitosan.

[0055] A method for preparing a wound protection sponge specifically comprises the following steps:

[0056] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 12 g of succinic acid was added and mixed to prepare a gel.

[0057] Preparation of wound protection sponge: firstly adjusting the pH value of the gel to 7.0, then freezing at -10°C for 20 hours, and then freeze-drying for 20 hours to obtain the wound protection sponge.

[0058] Example 4

[0059] A modified chitosan, the structural formula of which is as follows:

[0060]

[0061] A method for preparing modified chitosan specifically comprises the following steps:

[0062] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 15 g of succinic acid was added and mixed to prepare a gel.

[0063] Preparation of modified chitosan: freezing the gel at 0° C. for 24 hours to obtain the modified chitosan.

[0064] A method for preparing a wound protection sponge specifically comprises the following steps:

[0065] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 15 g of succinic acid was added and mixed to prepare a gel.

[0066] Preparation of wound sponge: first adjust the pH value of the gel to 7.5, then freeze at 0°C for 24 hours, and then freeze-dry for 24 hours to obtain the wound sponge. Figure 2 , SEM images are shown in Figure 3 .

[0067] Example 5

[0068] A modified chitosan, the structural formula of which is as follows:

[0069]

[0070] A method for preparing modified chitosan specifically comprises the following steps:

[0071] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 15 g of succinic acid was added and mixed to prepare a gel.

[0072] Preparation of modified chitosan: freezing the gel at 0° C. for 24 hours to obtain the modified chitosan.

[0073] A method for preparing a wound protection sponge specifically comprises the following steps:

[0074] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 15 g of succinic acid was added and mixed to prepare a gel.

[0075] Preparation of mixed gel: firstly adjust the pH value of the gel to 7.5, add 15g of blood flow interrupting polysaccharide into the gel to obtain a mixed gel.

[0076] Preparation of wound sponge: Freeze the mixed gel at 0°C for 24 hours, and then freeze-dry at 0°C for 24 hours to obtain the wound sponge. Figure 4 , SEM images are shown in Figure 5 .

[0077] Example 6

[0078] A modified chitosan, the structural formula of which is as follows:

[0079]

[0080] A method for preparing modified chitosan specifically comprises the following steps:

[0081] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 6 g of succinic acid was added and mixed to prepare a gel.

[0082] Preparation of modified chitosan: freezing the gel at 0° C. for 24 hours to obtain the modified chitosan.

[0083] A method for preparing a wound protection sponge specifically comprises the following steps:

[0084] Preparation of gel: After 3 g of chitosan was evenly mixed with 50 mL of deionized water, 6 g of succinic acid was added and mixed to prepare a gel.

[0085] Preparation of mixed gel: firstly adjust the pH value of the gel to 7.5, add 6g of blood flow interrupting polysaccharide into the gel to obtain a mixed gel.

[0086] Preparation of wound protection sponge: freezing the mixed gel at -20°C for 8 hours, and then freeze-drying at -20°C for 8 hours to obtain the wound protection sponge.

[0087] Comparative Example 1

[0088] Preparation of gel: 3 g of chitosan was mixed evenly with 50 mL of deionized water, and then 1% acetic acid solution was added to mix to prepare gel.

[0089] Preparation of hemostatic sponge: freezing the gel at -20°C for 14 hours, and then freeze-drying for 14 hours to obtain the wound protection sponge.

[0090] Comparative Example 2

[0091] Kuaikang medical hemostatic sponge, manufactured by Guangzhou Kuaikang Medical Equipment Co., Ltd., Type A.

[0092] Antibacterial ability test:

[0093] The wound protection sponges prepared in Examples 1 to 3 of the present invention have basically the same antibacterial effects as the wound protection sponges prepared in Example 4, with an inhibition rate against Staphylococcus aureus of 20% to 25%, and an inhibition rate against Escherichia coli of 30% to 35%. The following tests are only performed on Example 4; the wound protection sponges prepared in Example 5 have basically the same antibacterial effects as the wound protection sponges prepared in Example 6, and the following tests are only performed on Example 5.

[0094] Figure 1 This is the infrared characterization image of succinic acid modified chitosan prepared in Example 4.

[0095] Figure 1 Medium 3300-3500cm -1 The absorption peak of hydroxyl group is 1650cm -1 The absorption peak of C=N is at 700cm -1 The absorption peak of CC is at .

[0096] Figure 2 This is a schematic diagram of the wound protection sponge prepared in Example 4 of the present invention.

[0097] Figure 3 This is a SEM image of the wound protection sponge prepared in Example 4 of the present invention. Figure 3 It can be seen that the prepared wound protection sponge has many pores and can absorb a large amount of liquid.

[0098] Figure 4 This is a schematic diagram of the wound protection sponge prepared in Example 5 of the present invention.

[0099] Figure 5 This is a SEM image of the wound protection sponge prepared in Example 5 of the present invention. Figure 5 It can be seen that the prepared wound protection sponge has many pores, can absorb a large amount of liquid, and the pore diameters are relatively uniform.

[0100] The wound protection sponges prepared in Example 4, Example 5, and Comparative Example 1 and the hemostatic sponge prepared in Comparative Example 2 were soaked in an extract for 1 hour, and then the extract was taken out for testing, wherein the extract was water.

[0101] Inhibition rate = (OD value of blank control group - OD value of bacterial solution containing sample) / OD value of blank control group × 100%.

[0102] Among them, OD value: absorbance.

[0103] Take an agarose culture dish, culture Escherichia coli and Staphylococcus aureus, place the extract in the culture dish in a constant temperature incubator at 37°C for 24 hours, and calculate the antibacterial rate. The results show that the antibacterial rate of the wound sponge prepared in Example 4 against Staphylococcus aureus reaches 23%, and the antibacterial rate against Escherichia coli reaches 34%; the antibacterial rate of the wound sponge prepared in Example 5 against Staphylococcus aureus reaches 25%, and the antibacterial rate against Escherichia coli reaches 35% respectively; while the antibacterial rate of ordinary chitosan wound sponge against Staphylococcus aureus is only 15%, and the antibacterial rate against Escherichia coli is only 20%; while the antibacterial rate of commercially available wound sponge against Staphylococcus aureus is only 17%, and the antibacterial rate against Escherichia coli is only 21%.

[0104] Although preferred embodiments of the present invention have been described, those skilled in the art may make additional changes and modifications to these embodiments once the basic inventive concepts are known, and all such changes and modifications fall within the scope of the present invention.

Claims

1. A modified chitosan, characterized in that: Its structural formula is as follows: 。 2. The method for preparing modified chitosan according to claim 1, characterized in that: The specific steps include: Preparation of gel: chitosan, water and succinic acid are prepared into gel; wherein the chitosan, water and succinic acid are in a ratio of 3g:50mL:6g-15g; Preparation of modified chitosan: reacting the gel at -30°C to 0°C for 8h to 24h to obtain the modified chitosan.

3. A method for preparing modified chitosan according to claim 2, characterized in that: The gel is reacted at -10°C for 16 hours to obtain the modified chitosan.

4. The method for preparing modified chitosan according to claim 3, characterized in that: The preparation method of the gel is as follows: chitosan is mixed with water, and then succinic acid is added and mixed evenly to form the gel.

5. Use of the modified chitosan prepared by the preparation method according to claim 2 in preparing wound protection sponge.

6. The use according to claim 5, characterized in that: The preparation method of the wound protection sponge is: The pH value of the gel is first adjusted to 6.5-7.5, then frozen at -30°C-0°C for 8h-24h, and then freeze-dried for 8h-24h to obtain the wound protection sponge.

7. The use according to claim 6, characterized in that: The wound protection sponge also includes blood flow interruption polysaccharide.

8. The use according to claim 7, characterized in that: The preparation method of the wound protection sponge is as follows: firstly adjust the pH value of the gel to 6.5-7.5, add blood flow stopping polysaccharide, mix well, freeze at -30°C-0°C for 8h-24h, and then freeze-dry for 8h-24h to obtain the wound protection sponge.

9. The use according to claim 8, characterized in that: The chitosan, water, succinic acid and blood-stopping polysaccharide are in a ratio of 3g:50mL:6g-15g:6g-15g.

Citation Information

Patent Citations

  • Method of manufacturing film or sheet having water swelling function

    JP2013067075A

  • KR20210052068A